Behrad Darvishi

1.6k total citations
41 papers, 1.2k citations indexed

About

Behrad Darvishi is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Behrad Darvishi has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Biomaterials. Recurrent topics in Behrad Darvishi's work include Cancer Cells and Metastasis (8 papers), Nanoparticle-Based Drug Delivery (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Behrad Darvishi is often cited by papers focused on Cancer Cells and Metastasis (8 papers), Nanoparticle-Based Drug Delivery (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Behrad Darvishi collaborates with scholars based in Iran, United States and Czechia. Behrad Darvishi's co-authors include Leila Farahmand, Keivan Majidzadeh‐A, Yunes Panahi, Rassoul Dinarvand, Fatemeh Atyabi, Fatemeh Beiraghdar, Mohsen Amini, Amirhossein Sahebkar, Anupam Bishayee and Seyed Mohammad Nabavi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Biochemistry and Free Radical Biology and Medicine.

In The Last Decade

Behrad Darvishi

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Behrad Darvishi Iran 21 490 223 205 171 138 41 1.2k
Liuqing Yang China 22 664 1.4× 228 1.0× 122 0.6× 225 1.3× 189 1.4× 74 1.6k
Chuanlong Guo China 25 627 1.3× 236 1.1× 200 1.0× 128 0.7× 189 1.4× 90 1.7k
Salman Ul Islam South Korea 18 430 0.9× 284 1.3× 88 0.4× 146 0.9× 112 0.8× 42 1.2k
Jun Ye China 23 662 1.4× 238 1.1× 239 1.2× 202 1.2× 255 1.8× 67 1.7k
Xingmei Duan China 26 847 1.7× 341 1.5× 181 0.9× 280 1.6× 235 1.7× 56 1.7k
Rong Liu China 22 794 1.6× 307 1.4× 185 0.9× 235 1.4× 123 0.9× 79 1.8k
Goutam Dey India 24 716 1.5× 349 1.6× 270 1.3× 253 1.5× 148 1.1× 46 1.7k
Jun‐Jen Liu Taiwan 23 783 1.6× 159 0.7× 181 0.9× 133 0.8× 160 1.2× 49 1.6k
Amit Singh Yadav India 18 528 1.1× 225 1.0× 216 1.1× 275 1.6× 117 0.8× 40 1.3k

Countries citing papers authored by Behrad Darvishi

Since Specialization
Citations

This map shows the geographic impact of Behrad Darvishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behrad Darvishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behrad Darvishi more than expected).

Fields of papers citing papers by Behrad Darvishi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behrad Darvishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behrad Darvishi. The network helps show where Behrad Darvishi may publish in the future.

Co-authorship network of co-authors of Behrad Darvishi

This figure shows the co-authorship network connecting the top 25 collaborators of Behrad Darvishi. A scholar is included among the top collaborators of Behrad Darvishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behrad Darvishi. Behrad Darvishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bahraminasab, Marjan, Leila Farahmand, Behrad Darvishi, et al.. (2024). A thermosensitive hydrogel for the sustained delivery of exosomes extracted from menstrual blood mesenchymal stem cells and frizzled antibody on triple-negative breast cancer cells in vitro. Journal of Drug Delivery Science and Technology. 101. 106144–106144. 1 indexed citations
2.
Darvishi, Behrad, et al.. (2022). Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance. British Journal of Cancer. 126(9). 1253–1263. 25 indexed citations
6.
Farahmand, Leila, et al.. (2017). Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents. Current Cancer Drug Targets. 18(8). 737–748. 32 indexed citations
7.
Darvishi, Behrad, Leila Farahmand, Zahra Eslami‐S, & Keivan Majidzadeh‐A. (2017). NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer. Tumor Biology. 39(6). 3726132291–3726132291. 33 indexed citations
8.
Motlagh, Soraya Nouraei, et al.. (2017). Measuring Equity in the Distribution of Physical and Human Resources in Health Sector among the Cities of Lorestan Province (2006-2014). SHILAP Revista de lepidopterología. 1 indexed citations
9.
Darvishi, Behrad, Leila Farahmand, & Keivan Majidzadeh‐A. (2017). Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer. Molecular Therapy — Nucleic Acids. 7. 164–180. 44 indexed citations
10.
Panahi, Yunes, et al.. (2017). Protective effects of flavonoids against Alzheimer’s disease-related neural dysfunctions. Biomedicine & Pharmacotherapy. 93. 218–229. 81 indexed citations
11.
Darvishi, Behrad, Azadeh Manayi, Antonio García‐Ríos, et al.. (2017). Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive review. World Journal of Gastroenterology. 23(28). 5097–5097. 155 indexed citations
12.
Majidzadeh‐A, Keivan, et al.. (2017). Extremely low frequency magnetic field enhances glucose oxidase expression in Pichia pastoris GS115. Enzyme and Microbial Technology. 98. 67–75. 15 indexed citations
13.
Esfandyari‐Manesh, Mehdi, Behrad Darvishi, Ali Mohammadi, et al.. (2016). Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity. Materials Science and Engineering C. 62. 626–633. 66 indexed citations
14.
Panahi, Yunes, et al.. (2016). Molecular mechanisms of curcumins suppressing effects on tumorigenesis, angiogenesis and metastasis, focusing on NF-κB pathway. Cytokine & Growth Factor Reviews. 28. 21–29. 51 indexed citations
15.
Darvishi, Behrad, Yunes Panahi, Mostafa Ghanei, & Leila Farahmand. (2016). Investigating Prevalence and Pattern of Long‐term Cardiovascular Disorders in Sulphur Mustard‐exposed Victims and Determining Proper Biomarkers for Early Defining, Monitoring and Analysis of Patients’ Feedback on Therapy. Basic & Clinical Pharmacology & Toxicology. 120(2). 120–130. 3 indexed citations
16.
Esfandyari‐Manesh, Mehdi, Reza Faridi‐Majidi, Mohsen Amini, et al.. (2015). Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles. DARU Journal of Pharmaceutical Sciences. 23(1). 28–28. 42 indexed citations
17.
Rahimifard, Mahban, Mona Navaei‐Nigjeh, Maryam Baeeri, et al.. (2015). Reduction of chlorpyrifos-induced toxicity in human lymphocytes by selected phosphodiesterase inhibitors. Pesticide Biochemistry and Physiology. 128. 57–62. 11 indexed citations
18.
Panahi, Yunes, et al.. (2015). Chlorella vulgaris: A Multifunctional Dietary Supplement with Diverse Medicinal Properties. Current Pharmaceutical Design. 22(2). 164–173. 102 indexed citations
19.
Darvishi, Behrad, Golnaz Kamalinia, Mohsen Amini, et al.. (2013). Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. DARU Journal of Pharmaceutical Sciences. 21(1). 58–58. 104 indexed citations
20.
Jamalifar, Hossein, Nasrin Samadi, Mohsen Amini, et al.. (2012). Enhanced antibacterial activity of roxithromycin loaded pegylated poly lactide-co-glycolide nanoparticles. DARU Journal of Pharmaceutical Sciences. 20(1). 92–92. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026